ANG Lifesciences India Limited (BOM:540694)
India
· Delayed Price · Currency is INR 28.00
+0.17 (0.61%)
At close: Jun 27, 2025
ANG Lifesciences India Revenue
In the fiscal year ending March 31, 2025, ANG Lifesciences India had annual revenue of 928.47M INR, down -36.45%. ANG Lifesciences India had revenue of 168.23M in the quarter ending March 31, 2025, a decrease of -55.54%.
Revenue
928.47M
Revenue Growth
-36.45%
P/S Ratio
0.41
Revenue / Employee
2.14M
Employees
433
Market Cap
378.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 928.47M | -532.63M | -36.45% |
| Mar 31, 2024 | 1.46B | -737.81M | -33.55% |
| Mar 31, 2023 | 2.20B | -1.34B | -37.94% |
| Mar 31, 2022 | 3.54B | 2.00B | 129.50% |
| Mar 31, 2021 | 1.54B | 275.48M | 21.72% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |